Nuformix plc
NFX.L · LSE
9/30/2024 | 9/30/2023 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | – | £0 |
| % Growth | – | – | – | – |
| Gross Profit | £0 | -£0 | – | £0 |
| % Margin | – | – | – | 22.7% |
| EBITDA | -£0 | -£0 | – | -£0 |
| % Margin | – | – | – | -2,466.6% |
| Net Income | -£0 | -£0 | – | -£0 |
| % Margin | – | – | – | -2,218% |
| EPS Diluted | -0.005 | -0.001 | – | -0.002 |
| % Growth | -475% | – | – | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |